Links between headache mechanisms and new medications

Area of Science:

• Neuroscience
• Pharmacology
• Pain Research

Background:

• Migraine (M) treatment evolved from ergotamine's analgesic effects to serotonin antagonists like methysergide, supporting the serotonin theory of M.
• Advances in drug development have expanded therapeutic options while highlighting complex pathogenetic questions in migraine.

Purpose of the Study:

• To explore the theory that idiopathic headaches (IH) result from an automatism in pain signal transmission along neuroaxial sensory pathways.
• To investigate the role of faulty supraspinal pain modulation systems in headache pathogenesis.
• To examine the potential contribution of neurogenic edema (NGE) and neurogenic inflammation to headache pain.

Main Methods:

• Review of existing theories on migraine and idiopathic headache pathogenesis.
• Discussion of animal experiments demonstrating substance P (SP) release and its effects.
• Analysis of edema induction via substance P and histamine in animal models.

Main Results:

• Pain in IH may be caused by an automatism in pain signal transmission due to impaired supraspinal pain modulation.
• Activation of afferents can lead to antidromic release of substance P (SP), causing neurogenic edema (NGE) via capillary permeabilization.
• Edema induced by SP is not inherently painful but can cause pain in sensitive areas like the head, suggesting a role in headache.

Conclusions:

• Repeated NGE episodes may lead to sterile phlogosis (neurogenic inflammation).
• Neurogenic inflammation could be a mechanism that increases and prolongs peripheral pain in headaches.
• Understanding these mechanisms may offer new therapeutic targets for migraine and other headaches.